Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Zaidi

Showing results (361-370 of 413) with videos related to

Pageof 42
Sort By:
Frontiers in Oncology|August 4, 2022
Radiomic Features From Diffusion-Weighted MRI of Retroperitoneal Soft-Tissue Sarcomas Are Repeatable and Exhibit Change After RadiotherapyImogen Thrussell, Jessica M Winfield, Matthew R Orton, et al.
The Plant Genome|May 3, 2017
Use of Genomic Estimated Breeding Values Results in Rapid Genetic Gains for Drought Tolerance in MaizeB S Vivek, Girish Kumar Krishna, V Vengadessan, et al.
Annals of Surgery|October 8, 2015
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal AdenocarcinomaJuliann E Kosovec, Ali H Zaidi, Lori A Kelly, et al.
The American Journal of Gastroenterology|February 11, 2025
Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett EsophagusSarah E Laun, Lisa Kann, Jerome Braun, et al.
The Journal of Liquid Biopsy|July 3, 2026
Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumorsMuhammad Anees, Patrick L Wagner, Ashten Omstead, et al.
Oncoimmunology|May 13, 2022
OX40 and 4-1BB delineate distinct immune profiles in sarcomaM J Melake, H G Smith, D Mansfield, et al.
BMC Cancer|February 5, 2016
Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinomaAli H Zaidi, Lori A Kelly, Rachael E Kreft, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 9, 2025
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (UDCA): A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMaadeha H Zaidi, Zaroon Haider, Fnu Sadia, et al.
Gut|November 19, 2024
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the <i>EMERALD</i> multicentre studyJinsei Miyoshi, Alessandro Mannucci, Marco Scarpa, et al.
Tissue Engineering. Part A|September 28, 2018
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell PhenotypeLindsey T Saldin, Shil Patel, Li Zhang, et al.
Pageof 42

Showing results (361-370 of 413) with videos related to

Sort By:
Pageof 42
Frontiers in Oncology|August 4, 2022
Radiomic Features From Diffusion-Weighted MRI of Retroperitoneal Soft-Tissue Sarcomas Are Repeatable and Exhibit Change After RadiotherapyImogen Thrussell, Jessica M Winfield, Matthew R Orton, et al.
The Plant Genome|May 3, 2017
Use of Genomic Estimated Breeding Values Results in Rapid Genetic Gains for Drought Tolerance in MaizeB S Vivek, Girish Kumar Krishna, V Vengadessan, et al.
Annals of Surgery|October 8, 2015
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal AdenocarcinomaJuliann E Kosovec, Ali H Zaidi, Lori A Kelly, et al.
The American Journal of Gastroenterology|February 11, 2025
Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett EsophagusSarah E Laun, Lisa Kann, Jerome Braun, et al.
The Journal of Liquid Biopsy|July 3, 2026
Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumorsMuhammad Anees, Patrick L Wagner, Ashten Omstead, et al.
Oncoimmunology|May 13, 2022
OX40 and 4-1BB delineate distinct immune profiles in sarcomaM J Melake, H G Smith, D Mansfield, et al.
BMC Cancer|February 5, 2016
Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinomaAli H Zaidi, Lori A Kelly, Rachael E Kreft, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 9, 2025
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists for Patients With Primary Biliary Cholangitis With Inadequate Response to Ursodeoxycholic Acid (UDCA): A Systematic Review and Meta-Analysis of Randomized Controlled TrialsMaadeha H Zaidi, Zaroon Haider, Fnu Sadia, et al.
Gut|November 19, 2024
Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the <i>EMERALD</i> multicentre studyJinsei Miyoshi, Alessandro Mannucci, Marco Scarpa, et al.
Tissue Engineering. Part A|September 28, 2018
Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell PhenotypeLindsey T Saldin, Shil Patel, Li Zhang, et al.
Pageof 42